Table 3.
Distributions of FcγRIIIa categories in controls, SLE participants, and SLE participants stratified by nephritis phenotype.
| FcγRIIIa-66(R/H/L)+176(F/V) |
|||||
|---|---|---|---|---|---|
| High | Mid | Low | X2p | ||
| European Americans | Control | 58 | 237 | 890 | |
| SLE all | 36 | 172 | 626 | 0.8301 | |
| SLE neph (−) | 30 | 130 | 486 | ||
| SLE neph (+) | 6 | 43 | 139 | 0.9722 | |
|
| |||||
| African Americans | Control | 12 | 128 | 813 | |
| SLE all | 12 | 84 | 552 | 0.7297 | |
| SLE neph (−) | 11 | 51 | 279 | ||
| SLE neph (+) | 1 | 33 | 273 | 0.0024 | |
SLE neph (−): SLE patients negative for nephritis; SLE neph (+): SLE positive for nephritis.